Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of MCP-1 disclosed by Zeneca for inflammation

March 25, 1999

Amgen patents novel hydroxamic acid-based MMP inhibitors

March 22, 1999

Pfizer discloses selective hydroxamic acid-based MMP-13 inhibitors

March 19, 1999

FDA approves Prosorba Column for use in rheumatoid arthritis

March 18, 1999

Celgene describes new series for reducing TNF-alpha levels

March 18, 1999

Peripheral cannabinoid receptor ligands in development at Japan Tobacco

March 16, 1999

Roberts acquires Lodine rights in the U.K. and Ireland

March 12, 1999

Vertex initiates phase I clinical trial with VX-745

March 11, 1999

Cypress Bioscience and Fresenius sign definitive agreement for Prosorba Column

March 11, 1999

Merck Frosst presents clinical data on COX-2 inhibitor at Canadian meeting

March 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.